Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study
Authors:
- Keun-Sik HongKHKeun-Sik Hong
- Sun Uck KwonSKSun Uck Kwon
- Jae-Kwan ChaJCJae-Kwan Cha
- Jin-Man JungJJJin-Man Jung
- Yong-Jae KimYKYong-Jae Kim
- Kyung Bok LeeKLKyung Bok Lee
- Sung Il SohnSSSung Il Sohn
- Yong-Seok LeeYLYong-Seok Lee
- Joung-Ho RhaJRJoung-Ho Rha
- Jee-Hyun KwonJKJee-Hyun Kwon
- Sang Won HanSHSang Won Han
- Bum Joon KimBKBum Joon Kim
Open Access
- 1 January 2021
- journal article
- research article
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (3) , 344-353
Abstract
Hong KS, et al. J Clin Neurol. 2021 Jul;17(3):344-353. https://doi.org/10.3988/jcn.2021.17.3.344Keywords
Funding Information
- Boryung Pharmaceutical Co., Ltd.
This publication has 18 references indexed in Scilit:
- Blood Pressure Reduction and Secondary Stroke PreventionHypertension, 2017
- Case Characteristics, Hyperacute Treatment, and Outcome Information from the Clinical Research Center for Stroke-Fifth Division Registry in South KoreaJournal of Stroke, 2015
- Consistency of Blood Pressure Control After Ischemic StrokeStroke, 2014
- Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent StrokeJAMA, 2011
- Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-StrokeCirculation: Cardiovascular Quality and Outcomes, 2010
- Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literatureHypertension Research, 2009
- Analysis of 16,922 Patients with Acute Ischemic Stroke and Transient Ischemic Attack in JapanCerebrovascular Diseases, 2004
- Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular EventsStroke, 2003
- Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data BankStroke, 2001
- Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 2001